SaMD for Pharma | Huma
SaMD for Pharma
Smarter patient care
Remote patient monitoring and automated triage help optimise treatment and outcomes by reducing physician administrative workload.
Huma's EU MDR Class IIb approved and Class II FDA 510(k) cleared platform as a medical device platform enables early identification of patient condition changes, allowing for more timely and appropriate interventions.
How AI, Huma and pharmaceuticals are transforming healthcare
Take preventative health for example. Huma has partnered with Bayer, helping to develop the Bayer Aspirin Heart Risk Assessment. Huma developed an algorithm using data from the UK’s Biobank which predicts long-term risk of cardiovascular disease. Through a user-friendly questionnaire, individuals can determine whether they fall into higher, average, or lower risk categories for developing CVD.
Combining Huma’s platform capabilities, together with AI, will lead to further initiatives in predictive health.
Huma has the expertise and knowledge to build AI models with our partners that can revolutionise the way healthcare is delivered.
Improving clinical outcomes
90-95% Adherence and retention rates across our care and research deployments are the result of high engagement rates
x2 Our platform can almost double clinical capacity and reduce readmission rates by >30%
3-4x lower mortality amongst Huma patients compared with patients not using Huma
88.2% of patients highlighted as deteriorating had operation dates brought forward
Clinical Outcomes. Improved.
Huma’s regulated platform enables faster, smarter clinical decision-making, resulting in earlier intervention, better patient experience and improved outcomes.
With a single view of the patient on one convenient dashboard, clinicians can identify at-risk patients earlier and make timely interventions sooner—especially for patients with multiple comorbidities.
Educate. Engage. Retain.
Keep more patients engaged and in adherence longer with highly configurable modules that flex to your needs and deliver more personalised care and support.
Our award-winning user experience design, combined with evidence-based patient education, symptom tracking and ongoing communication, result in better adherence to medication and treatment plans and sustained usage of the Huma app over time.
Real-World Evidence. Delivered.
Collect real-world, clinically meaningful data at scale across your operating markets for more accurate, more complete outcomes reporting.
Huma Cloud Platform captures real-world data across multiple therapeutic areas and patient registries, which can be aggregated to provide valuable insights at an individual, patient cohort, and population level.
Regulatory, safety and compliance
Regulatory compliance
- FDA 510k Class II (USA)
- HIPAA Compliant (USA)
- MHRA Class IIb (UK)
- CDSCO Class C (India)
- EU MDR Class IIb (EU)
- TGA Class IIb (Australia)
- Saudi FDA Class C (Saudi Arabia)
- MOHAP (UAE)
- MDSAP (Japan, Australia, Canada, US)
- NHS DSPT (UK)
International medical device standards
- IEC 62304
- IEC 62366
- IEC 82304-1
- ISO 14971
- ISO 14155
QMS & info security management
- ISO 13485
- ISO 27001
- 21CFR820 (QSR)
- SOC 2 Type II
Technical documentation
- Complete STED file
- Audits passed by Notified Bodies